Buscar
Pfizer Inc
PFEAñadir a la lista de seguimiento
24.480USD
+0.310+1.28%
Cierre 07/13, 16:00（ET）Cotizaciones retrasadas 15 min
139.52BCap. mercado
18.59P/E TTM
Más Datos de Pfizer Inc Compañía
Pfizer Inc. is a research-based, global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, Hympavzi, Sulperazon, Zavicefta, Octagam and others.
Información de Pfizer Inc
Símbolo de cotizaciónPFE
Nombre de la empresaPfizer Inc
Fecha de salida a bolsaFeb 22, 2080
Director ejecutivoBourla (Albert)
Número de empleados81000
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 22
Dirección66 Hudson Boulevard East
CiudadNEW YORK
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal10001-2192
Teléfono12127332323
Sitio Webhttps://www.pfizer.com/
Símbolo de cotizaciónPFE
Fecha de salida a bolsaFeb 22, 2080
Director ejecutivoBourla (Albert)
Ejecutivos de Pfizer Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Albert Bourla, Ph.D.
Dr. Albert Bourla, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
394.63K
+4.08%
Mr. Douglas M. Lankler
Mr. Douglas M. Lankler
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
165.26K
+2.36%
Ms. Sally Susman
Ms. Sally Susman
Executive Vice President, Chief Corporate Affairs Officer
Executive Vice President, Chief Corporate Affairs Officer
95.94K
+7.61%
Mr. Michael (Ike) Mcdermott
Mr. Michael (Ike) Mcdermott
Executive Vice President, Chief Global Supply Officer
Executive Vice President, Chief Global Supply Officer
68.47K
-3.36%
Ms. Lidia L. Fonseca
Ms. Lidia L. Fonseca
Executive Vice President, Chief Digital and Technology Officer
Executive Vice President, Chief Digital and Technology Officer
32.73K
+5.39%
Mr. Ronald E. Blaylock
Mr. Ronald E. Blaylock
Independent Director
Independent Director
32.46K
--
Mr. Aamir Malik
Mr. Aamir Malik
Executive Vice President, Chief US Commercial Officer
Executive Vice President, Chief US Commercial Officer
29.55K
--
Ms. Payal Sahni
Ms. Payal Sahni
Executive Vice President, Chief People Experience Officer
Executive Vice President, Chief People Experience Officer
26.59K
+6.54%
Dr. Scott Gottlieb, M.D.
Dr. Scott Gottlieb, M.D.
Independent Director
Independent Director
10.00K
--
Mr. Cyrus Taraporevala
Mr. Cyrus Taraporevala
Independent Director
Independent Director
10.00K
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Albert Bourla, Ph.D.
Dr. Albert Bourla, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
394.63K
+4.08%
Mr. Douglas M. Lankler
Mr. Douglas M. Lankler
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
165.26K
+2.36%
Ms. Sally Susman
Ms. Sally Susman
Executive Vice President, Chief Corporate Affairs Officer
Executive Vice President, Chief Corporate Affairs Officer
95.94K
+7.61%
Mr. Michael (Ike) Mcdermott
Mr. Michael (Ike) Mcdermott
Executive Vice President, Chief Global Supply Officer
Executive Vice President, Chief Global Supply Officer
68.47K
-3.36%
Ms. Lidia L. Fonseca
Ms. Lidia L. Fonseca
Executive Vice President, Chief Digital and Technology Officer
Executive Vice President, Chief Digital and Technology Officer
32.73K
+5.39%
Mr. Ronald E. Blaylock
Mr. Ronald E. Blaylock
Independent Director
Independent Director
32.46K
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Pfizer Inc?
Los cinco principales accionistas de Pfizer Inc son: Dr. Albert Bourla, Ph.D.
¿Cuántas instituciones poseen acciones de Pfizer Inc (PFE)?
A fecha de 2026Q1, 4824 instituciones poseen acciones de Pfizer Inc, con un valor de mercado combinado de aproximadamente 3.98B, lo que representa el 69.87% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 29483336.00.
¿Cuál es la mayor fuente de ganancias de Pfizer Inc?
El 2026Q1, el segmento empresarial Eliquis alliance revenues and direct sales generó la ganancia más alta para Pfizer Inc, ascendiendo a 7.96B y representando el 12.72% de la ganancia total.